Renovorx (RNXT) traded up 6.11 % during a 24 hours period ending at 10:49 AM Central Europe on Wednesday 28th. One Renovorx stock can currently be bought for about USD 1.39 on popular exchanges. Current supply of Renovorx stocks is 44.8 mn. Renovorx has a current market capitalization of USD 59.1 mn and approximately USD 402.3 k worth of Renovorx was traded on exchanges in the last 24 hours. Since last month end, Renovorx has traded -10.32 % down. Simple moving average of last 200 days is at USD 1.1. The highest price of past 52 weeks was recorded at USD 2.59 on 09/02/2026. 52 weeks low was at USD 0.7 on 11/14/2025.
Here is how related stocks have performed in the past 24 hours:
Calisa Acquisition (ALIS) traded up 2.56 % and now trades at USD 8.41. Calisa Acquisition has a market capitalisation of USD 69.1 mn. Current price/earnings ratio for Calisa Acquisition is 112.8.
Cognition Therapeutics (CGTX) traded up 9.21 % and now trades at USD 0.76. Current market capitalisation for Cognition Therapeutics is USD 69.5 mn.
Neonc (NTHI) traded up 6.38 % and now trades at USD 3. Neonc has a market capitalisation of USD 70.1 mn.
Medicinova (MNOV) traded up 0.71 % and now trades at USD 1.41. Current market capitalisation for Medicinova is USD 68.4 mn.
Electrocore (ECOR) traded up 4.3 % and now trades at USD 7.76. Current market capitalisation for Electrocore is USD 70 mn.
About Renovorx
RenovoRx, Inc. is a clinical-stage biopharmaceutical company based in Los Altos, California, USA. The company specializes in developing therapies for the local treatment of solid tumors and targeted chemotherapy delivery for pancreatic cancer patients.